AbbVie completes acquisition of Landos Biopharma to strengthen immunology portfolio

AbbVie Inc. (NYSE: ABBV), a global biopharmaceutical leader, has announced the completion of its acquisition of Landos Biopharma, Inc. (NASDAQ: LABP), a clinical-stage biopharmaceutical company, ... Read More